Paper3943032
The interaction of hematoporphyrin derivative, light, and ionizing radiation in a rat glioma model.
Kostron H and 3 others. Cancer, 1986. Cited by 74 papers, by iCite.
Cite this record
ConductScience Library. The interaction of hematoporphyrin derivative, light, and ionizing radiation in a rat glioma model. Papers, record 3943032. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3943032
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cobalt Radioisotopes | Major topic |
| Glioma | Major topic |
| Hematoporphyrin Photoradiation | Major topic |
| Photochemotherapy | Major topic |
| Animals | |
| Combined Modality Therapy | |
| Disease Models, Animal | |
| Dose-Response Relationship, Drug | |
| Hematoporphyrins | |
| Male | |
| Rats | |
| Time Factors | |
| Tumor Stem Cell Assay |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| K07 NS00654 | NINDS NIH HHS | United States | K07NS000654 | PubMed and NIH |
Source NIH RePORTER
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41752953 | 5-Aminolevulinic Acid-Based Radiodynamic Therapy for Malignant Gliomas: A Conceptual Framework for Mitochondria-Centered Mechanisms, Target Cell States and Translational Perspectives. | Life (Basel) | 2026 | https://conductscience.org/library/papers/41752953 | PubMed |
| 40526132 | 5-Aminolevulinic acid as an emerging radiosensitizer for radiodynamic therapy in solid tumors: a systematic review of available data and clinical potential. | Strahlenther Onkol | 2025 | https://conductscience.org/library/papers/40526132 | PubMed |
| 35094359 | Nanoscintillator-Based X-Ray-Induced Photodynamic Therapy. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35094359 | PubMed |
| 31080554 | Low dose photodynamic therapy harmonizes with radiation therapy to induce beneficial effects on pancreatic heterocellular spheroids. | Oncotarget | 2019 | https://conductscience.org/library/papers/31080554 | PubMed |
| 30063116 | Nanoparticles to mediate X-ray-induced photodynamic therapy and Cherenkov radiation photodynamic therapy. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2019 | https://conductscience.org/library/papers/30063116 | PubMed |
| 26309688 | Cyclin D1 G870A polymorphism and glioma risk in a Chinese population. | Int J Clin Exp Med | 2015 | https://conductscience.org/library/papers/26309688 | PubMed |
| 25013509 | DNA repair gene XRCC3 Thr241Met polymorphism and susceptibility to glioma: A case-control study. | Oncol Lett | 2014 | https://conductscience.org/library/papers/25013509 | PubMed |
| 24212824 | Enhancing photodynamyc therapy efficacy by combination therapy: dated, current and oncoming strategies. | Cancers (Basel) | 2011 | https://conductscience.org/library/papers/24212824 | PubMed |
| 24048757 | Three polymorphisms of DNA repair gene XRCC1 and the risk of glioma: a case-control study in northwest China. | Tumour Biol | 2014 | https://conductscience.org/library/papers/24048757 | PubMed |
| 10944608 | Effect of photodynamic therapy in combination with ionizing radiation on human squamous cell carcinoma cell lines of the head and neck. | Br J Cancer | 2000 | https://conductscience.org/library/papers/10944608 | PubMed |
| 10582664 | An indwelling brachytherapy balloon catheter: potential use as an intracranial light applicator for photodynamic therapy. | J Neurooncol | 1999 | https://conductscience.org/library/papers/10582664 | PubMed |
| 7734319 | Anti-tumour activity of photodynamic therapy in combination with mitomycin C in nude mice with human colon adenocarcinoma. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7734319 | PubMed |
| 2976084 | Photodynamic therapy is potentiated by Co60 and intratumoral injection of hematoporphyrin derivative. | J Neurooncol | 1988 | https://conductscience.org/library/papers/2976084 | PubMed |
| 2965572 | Photodynamic effects of haematoporphyrin derivative on DNA repair in murine L929 fibroblasts. | Biochem J | 1987 | https://conductscience.org/library/papers/2965572 | PubMed |
| 2390482 | The effect of combined modality treatment with ionising radiation and TPPS-mediated photodynamic therapy on murine tail skin. | Br J Cancer | 1990 | https://conductscience.org/library/papers/2390482 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3943032
GET https://conductscience.org/api/papers/v1/3943032/authors